Europe Gene Synthesis Market Size, Share & Industry Trends Analysis Report By Method, By Service Type, By Application, By End User, By Country, Historical Data and Growth Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Europe Gene Synthesis Market
Market Report Description
The Europe Gene Synthesis Market would witness market growth of 17.4% CAGR during the forecast period (2021-2027).
The purpose of gene synthesis is to chemically synthesize the DNA oligonucleotides and their assembly into circuits, synthons, genes, and complete genomes and build, design, test, learn, and repeat the cycle underpinning the innovations in synthetic biology.
Sequencing, amplification, and automation are now the essential parts of the clinical research procedures centered on life science domains like cancer biology, genetics, neuroscience, antibody engineering, and biochemistry. These factors are consecutively increasing the growth and development related to the gene synthesis sciences.
As stated in a report of the European parliament, synthetic biology is considered as one of the continuously developing technologies. The increase in the funding and investments by pharmaceutical and biotech organizations with the purpose to enhance the quality and quantity of researches and developments in the field of synthetic biology would also be a major factor for the development of the gene synthesis processes across the region.
The Germany market dominated the Europe Gene Synthesis Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $362 million by 2027. The UK market would witness a CAGR of 16.6% during (2021 - 2027). Additionally, The France market is poised to grow a CAGR of 18.3% during (2021 - 2027).
Based on Method, the market is segmented into Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis. Based on Service Type, the market is segmented into Antibody DNA Synthesis, Viral DNA Synthesis and Others. Based on Application, the market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others. Based on End User, the market is segmented into Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Gene Synthesis Market Size will Hit $5.2 Billion by 2027, at a CAGR of 17.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.
Scope of the Study
Market Segments Covered in the Report:
- Solid-phase Synthesis
- Chip-based Synthesis and
- PCR-based Enzyme Synthesis
By Service Type
- Antibody DNA Synthesis
- Viral DNA Synthesis and
- Gene & Cell Therapy Development
- Vaccine Development
- Disease Diagnosis and
By End User
- Academic & Government Research Institutes
- Biotechnology & Pharmaceutical Companies and
- Contract Research Organizations
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Genscript Biotech Corporation
- Thermo Fisher Scientific, Inc.
- Brooks Automation, Inc.
- Boster Biological Technology
- Twist Bioscience Corporation
- Danaher Corporation
- Biomatik Corporation
- ProMab Biotechnologies, Inc.
- OriGene Technologies, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free